Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: A gate driving circuit includes a first switch element, a second switch element, a third switch element, a fourth switch element, a fifth switch element, and a sixth switch element. Wherein, the third switch element receives a reference low level voltage to stabilize the voltage of a pull-up control node. A stabilization module consisting of the fourth switch element, the fifth switch element and the sixth switch element is configured to stabilize the voltage of a gate drive signal outputted by a fourth conductive terminal of the second switch element during a non-scanning period.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: The application provides a method and an apparatus for network capacity expansion, including collecting online record information of mobile users in a plurality of cells; respectively acquiring target service types in each of the cells; for each cell, acquiring rates of the target service types in the cell; for each of the target service types, acquiring a target rate of the target service type; for each cell, acquiring a target rate experienced by the individual user and an actual average rate experienced by the user in the cell; for each cell, determining a target cell according to the target rate experienced by the individual user and the actual average rate experienced by the user in the cell, as well as the utilization ratio of the wireless resources and the number of the online users; performing the network capacity expansion on the target cell.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: The present invention is related to a surface control additive for a radiation curing system, the method for its preparation as well as its application. The surface control additive has the following structure: wherein A is wherein m is an integer from 0 to 400, n is an integer from 1 to 500, x is an integer from 0 to 800, p is an integer from 0 to 600, q is an integer from 1 to 800, R4 and R5 are H or CH3 respectively, R6 is H or a linear or a branched alkyl group containing 1-18 carbon atoms or an acyl group containing 2-5 carbon atoms. The surface control additive of the present invention is applied to radiation curing (UV/EB) paint and inks, enables the coatings to maintain non-adhesive and smooth for a long time, and minimizes transferable precipitates from a cured film. In addition, by using different combinations of EO and PO, the surface control additive of the present invention can adapt to a free selection from high-polarity aquosity to a low-polarity aliphatic hydrocarbon solvent system.

Abstract: A condensation enhancement heat transfer pipe that includes an optical pipe section, a fin section, and a transition section connecting the optical pipe section and the fin section. The outer surface of the fin section includes a plurality of individual fins, each having an acute shape of zigzag and forms an angle relative to the axial direction, an axial fin channel forms between the two adjacent ones of said individual fins along the axial direction, a peripheral fin channel forms between the two adjacent ones of said individual fins along the peripheral direction, an end, which is distributed along said axial direction, of each of said individual fins includes platforms, the fin side walls are connected with the platform by an arc, and the platforms are parallel to each other along the peripheral direction.

Abstract: The present invention is related to a polyurethane dispersant and a preparation method thereof. The polyurethane dispersant is terminated by a nitrogen-containing heterocyclic compound during synthesis. The nitrogen-containing heterocyclic compound is prepared by subjecting anhydride and a compound containing a primary amine and a secondary amine or a hydroxyl or mercapto group to dehydration condensation. The condensed product is the nitrogen-containing heterocyclic compound, containing a reactive hydrogen. The structural formula of the compound containing the primary amine and the secondary amine or hydroxyl or mercapto group is shown as follows: wherein n=1 to 5, and preferably 2 to 4, R1 and R2 are respectively alkyls containing 1 to 8 carbons, R1 and R2 are independent of each other or connected by a chemical bond to form one or more saturated or unsaturated 4-member to 8-member rings, and X represents N, O, or S.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: The present disclosure discloses a method and device for invoking a JAVA card object. The method comprises: receiving, by a JCRE, a service request message transmitted by an application Applet1; acquiring, by the JCRE, interaction information between the Applet1 and the Applet2 according to an ID of the Applet1 and an ID of the Applet2; acquiring, by the JCRE, a trust degree between the Applet1 and the Applet2 according to the interaction information between the Applet1 and the Applet2, information about one interaction comprising service class information for this interaction and information about whether a service request task of the Applet1 succeeds after this interaction; and determining, by the JCRE, that the Applet1 invokes a shared interface service of the Applet2, when the trust degree reaches a trust degree threshold.

Abstract: Embodiments of the present disclosure disclose an identity authentication method and device. The method comprises: receiving, by an identity authentication server, an identity authentication request transmitted by a third-party platform; determining, according to the phone number, an ID of a first identity authentication client by searching a pre-stored correspondence; if the first identity authentication client is online, transmitting a user information request; transmitting an authentication success message to the third-party platform if a user information response carrying the user information is received and the user information is consistent with user information stored in the identity authentication server; or transmitting an authentication fail message to the third-party platform if the user information is inconsistent with user information stored in the identity authentication server, or if a user information response carrying the user information is not received.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.